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ABSTRACT
Objectives To explain methods for data synthesis of evidence from diagnostic test accuracy (DTA) studies, and to illustrate different types of
analyses that may be performed in a DTA systematic review.
Methods We described properties of meta-analytic methods for quantitative synthesis of evidence. We used a DTA review comparing the accuracy
of three screening questionnaires for bipolar disorder to illustrate application of the methods for each type of analysis.
Results The discriminatory ability of a test is commonly expressed in terms of sensitivity (proportion of those with the condition who test positive)
and speciﬁcity (proportion of those without the condition who test negative). There is a trade-off between sensitivity and speciﬁcity, as an
increasing threshold for deﬁning test positivity will decrease sensitivity and increase speciﬁcity. Methods recommended for meta-analysis of DTA
studies –such as the bivariate or hierarchical summary receiver operating characteristic (HSROC) model –jointly summarise sensitivity and speciﬁcity
while taking into account this threshold effect, as well as allowing for between study differences in test performance beyond what would be
expected by chance. The bivariate model focuses on estimation of a summary sensitivity and speciﬁcity at a common threshold while the HSROC
model focuses on the estimation of a summary curve from studies that have used different thresholds.
Conclusions Meta-analyses of diagnostic accuracy studies can provide answers to important clinical questions. We hope this article will provide
clinicians with sufﬁcient understanding of the terminology and methods to aid interpretation of systematic reviews and facilitate better patient care.
INTRODUCTION
Diagnostic accuracy is the ability of a test to correctly identify or
exclude a target condition and is a fundamental part of the evaluation
of medical tests. Test accuracy is estimated by comparing results of an
index test (a new or existing test of interest) with a reference standard,
sometimes known as a ‘gold’ standard, to give a 2×2 table of the
number of true positives, false positives, false negatives and true nega-
tives (table 1). The reference standard is used to verify the presence or
absence of the target condition, and may be a single test or a combin-
ation of tests.1 The ideal index test should have no misclassiﬁcation
errors (false negatives or false positives), but in clinical practice such a
test is unlikely to exist.
Many test accuracy studies are small,2 and even when studies are
large, the number of cases may be small due to the low prevalence of
the target condition. A systematic review and meta-analysis of diagnos-
tic test accuracy (DTA) aims to identify and summarise evidence on the
accuracy of tests, including an assessment of the quality and consist-
ency of the evidence. Pooling the results of multiple studies addressing
the same question using meta-analysis will provide a more precise esti-
mate of test performance than is possible in a single study. The extent
of variability in test performance between studies (heterogeneity) can
be quantiﬁed in a meta-analysis and formal investigations of potential
sources of heterogeneity may also be performed in order to explain
why results differ between studies.
The rate of publication of systematic reviews and meta-analyses of
diagnostic accuracy has risen considerably since the 1990s,3 and they
are being used to inform evidence-based clinical practice guidelines and
healthcare policy.4–7 Producing DTA reviews is more complex than
reviews of interventions.8 9 Meta-analysis is one of the challenging
aspects because traditional meta-analytic methods used for intervention
reviews are not appropriate for DTA reviews. It is vital that recom-
mended methods for pooling study results are well understood to
ensure appropriate application. In this paper, we summarise basic con-
cepts in diagnostic accuracy research as a prelude to explaining the
rationale for the methods recommended for DTA meta-analysis,
describe the properties of the methods, and use a published example
to illustrate their application in different types of analyses. We focus on
commonly used methods for situations where a single 2×2 table is
available, or can be derived for each study included in a meta-analysis.
BASIC CONCEPTS IN DIAGNOSTIC ACCURACY RESEARCH
It is important to be aware of both the types of data that tests produce
and the statistical measures used to summarise test accuracy.
Types of data
Test results may be expressed as measurements (counts or continuous)
or classiﬁcations (binary or ordered categories). Standard methods for
computing test accuracy demand binary classiﬁcation of the results of
the index test and the reference standard (table 1). As such, for non-
binary data, criteria for determining test positivity, typically referred to
as thresholds, cut-offs or cut points, are needed to dichotomise the
data. Thresholds may be explicit numeric values or implicit based on
different criteria derived from subjective visual interpretation or mea-
surements. For example, various numeric thresholds have been used to
deﬁne a positive result for the Informant Questionnaire on Cognitive
Decline in the Elderly (IQCODE) for detection of dementia.10 Higher
scores are indicative of greater cognitive impairment, with a maximum
average score of 5. In a Cochrane DTA review, Quinn et al10 described
the test accuracy of the 16-item and 26-item IQCODE for thresholds of
3.3, 3.4, 3.5 and 3.6.
Types of measures of test accuracy
The most commonly used measures are summarised in table 2.
Measures are either paired or single (global) indicators of test perform-
ance. The paired measures—sensitivity and speciﬁcity, positive and
negative predictive values, and positive and negative likelihood ratios—
separately describe the performance of a test for ascertaining ﬁrst the
presence and then the absence of the target condition. Sensitivity and
speciﬁcity are the most commonly reported measures in primary
studies and are also used for meta-analysis.3 A receiver operating char-
acteristic (ROC) plot is used to show how as the test threshold
decreases (for a test where the presence of disease increases the
value of the test measurement such as the IQCODE example above)
sensitivity increases while speciﬁcity decreases, and vice versa.11 The
position of the ROC curve depends on the discriminatory ability of the
test; the more accurate the test is, the closer the curve to the upper
left hand corner of the ROC plot. A test that performed no better than
tossing a coin would have an ROC curve along the 45° axis.
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The most common global measures are the diagnostic OR (DOR) and
the area under the curve (AUC). These measures summarise the accur-
acy of the test across all possible thresholds, but are not helpful in clin-
ical practice because they do not provide information on the error rates
in the diseased (false negative) and non-diseased groups (false posi-
tives). The error rates are important for judging the extent and likely
impact of the downstream consequences of testing. In meta-analysis,
the DOR can be a useful measure when comparing tests or subgroups,
particularly if there is no preference for either superior sensitivity or spe-
ciﬁcity, and interest is in global performance.
TYPES OF ANALYSES IN A DIAGNOSTIC ACCURACY
REVIEW
Three main types of analyses can be performed in a DTA review reﬂect-
ing the types of questions and objectives that can be addressed.11
These are:
1. Analysis of a single test—What is the diagnostic accuracy of the
test?
2. Analysis comparing multiple tests—How does the accuracy of two
or more tests differ?
3. Investigation of heterogeneity—How does test accuracy vary with
clinical and methodological characteristics?
Each of these will be considered separately below, using an example.
First, the broad principles of the meta-analysis approaches are
discussed.
METHODS FOR META-ANALYSIS: BROAD PRINCIPLES
We recommend ﬁrst plotting the data—the results of each study can be
marked as a sensitivity and speciﬁcity point in a summary ROC (SROC)
plot which will depict the location of the data (consider how close the
points lie to the 100% sensitivity and 100% speciﬁcity lines); the scatter
of the points; and any relationship between sensitivity and speciﬁcity
obvious across multiple studies. Usually only one point is plotted per
study, but see the multiple thresholds discussion later. Since the different
studies included in a meta-analysis may explicitly use different thresh-
olds, or variations in the way the test is interpreted and applied, and
even the patient group may induce threshold-like differences between
studies, the recommended meta-analytical methods for test accuracy all
explicitly or implicitly allow for the negative correlation between sensitiv-
ity and speciﬁcity across studies that is induced by the threshold-like vari-
ation. Simple univariate meta-analytic methods pool sensitivity and
speciﬁcity separately, ignoring the potential threshold effect. Such ana-
lyses can give misleading results as illustrated by Irwig et al.12 An SROC
curve approach was developed by Moses et al13 to account for possible
heterogeneity in threshold, but the approach assumes that variation is
only due to the threshold effect and chance and does not allow for het-
erogeneity. Measures of test accuracy are not ﬁxed properties of a test
and often vary with the population, setting, characteristics and conduct
of the test (including skill and experience of assessors or practitioners),
and deﬁnition of the target condition. Therefore, heterogeneity is a
common feature of DTA reviews. The Moses SROC approach also has
other important methodological limitations14 15 and should only be used
for preliminary analyses.11
Special hierarchical models have been developed for DTA meta-analysis
that account for the negative correlation in paired measures across
studies and heterogeneity. These models are termed hierarchical
models because they involve statistical distributions at two levels;
within-study variability in sensitivity and speciﬁcity is taken into account
at the lower level, and between-study variability at the higher level.11
The bivariate16 17 and the hierarchical summary receiver operating char-
acteristic (HSROC) models18 are the two hierarchical models used for
meta-analysis when a single sensitivity and speciﬁcity pair is available
for each study.8 11
The focus of the bivariate model is estimation of a summary point
(summary sensitivity and speciﬁcity) at a common threshold. This
would be useful if studies used a standard threshold and clinicians
wanted to know how the test performed at that threshold (eg, the
Mini-Mental State Examination at a threshold of 24/30 indicating
normal). In contrast, the focus of the HSROC model is on estimating an
SROC curve across different thresholds (note this is not the same curve
as the Moses SROC curve). This would be useful if studies used a
variety of thresholds and clinicians wanted to get an idea of how the
test performed across the range of thresholds, or wanted to compare
tests without restricting comparison to a single threshold. Ideally, we
would like to know which threshold on the curve gives the best per-
formance, but the position of individual thresholds cannot be identiﬁed.
The bivariate and HSROC models have been shown to share statistical
properties.19 The choice of which model to use should ideally be driven
by the research question (ie, focus of inference on points or curves) but
is sometimes inﬂuenced by the nature of the available data (mixed
thresholds) and its effect on the interpretation of summary ﬁndings,
software capability and expertise of the team. Owing to their shared
statistical properties, SROC curves can be computed from bivariate
models and average operating points from HSROC models, so the
choice of model when there is only a single test is academic. When
there are comparisons between tests or subgroups, the choice of
model is important.
Bivariate meta-analysis of likelihood ratios and predictive values are
alternatives to bivariate meta-analysis of sensitivity and speciﬁcity but
have been noted to face additional challenges.20 21 Therefore, only
Table 1 Cross classification of index test and reference standard
results
Reference standard
positive
Reference standard
negative Total
Index test
positive
a (true positives) b (false positives) a+b (test
positives)
Index test
negative
c (false negatives) d (true negatives) c+d (test
negatives)
Total a+c (disease
positives)
b+d (disease
negatives)
a+b+c+d (study
total)
Table 2 Definition of common measures of test accuracy
Test accuracy
measure Formula* Definition
Sensitivity a/(a+c) Proportion of those with the target condition
correctly identified as having the condition
Specificity d/(b+d) Proportion of those without the target
condition correctly identified as not having the
condition
Positive predictive
value
a/(a+b) Proportion of those with the target condition
out of the test positives
Negative predictive
value
d/(c+d) Proportion of those without the target
condition out of the test negatives
Positive likelihood
ratio (LR+)
a=ðaþ cÞ
b=ðbþ dÞ
Ratio of the proportion that tests positive
among those with the target condition
compared to the proportion that tests positive
among those without the target condition
Negative likelihood
ratio (LR–)
c=ðaþ cÞ
d=ðbþ dÞ
Ratio of the proportion that tests negative
among those with the target condition
compared to the proportion that tests
negative among those without the target
condition
Diagnostic OR ad/bc or
LR+/LR–
Ratio of the odds of positivity in those who
have the target condition relative to the odds
of positivity in those without the condition
*Expressed based on the notation used in table 1.
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methods for summarising sensitivities and speciﬁcities are illustrated in
this paper. Other measures such as likelihood ratios can be derived from
functions of some of the parameters of bivariate or HSROC models
shown in table 3. The example below is used to illustrate different types
of analyses and the appropriate use of hierarchical models.
WORKING EXAMPLE: SCREENING TESTS FOR BIPOLAR
SPECTRUM DISORDERS
A DTA systematic review compared the diagnostic accuracy of three
screening questionnaires—the bipolar spectrum diagnostic scale
(BSDS), the hypomania checklist (HCL-32) and the mood disorder ques-
tionnaire (MDQ)—for detection of bipolar disorder (table 4).22 Studies
used different thresholds to deﬁne test positivity for each instrument.
The reference standards used were based on the Diagnostic and
Statistical Manual of Mental Disorders 4th Edition (DSM-IV) criteria.
The review included analyses for different settings and types of bipolar
disorder. Only the analysis of bipolar disorder in general in a mental
health centre setting is considered here (ﬁgure 1).
METHODS FOR META-ANALYSIS OF A SINGLE TEST
Data synthesis
Estimation of a summary sensitivity and speciﬁcity at a ﬁxed
threshold
The bivariate model jointly synthesises sensitivity and speciﬁcity to give
summary estimates which are drawn as the summary point on an
SROC plot. Conﬁdence and prediction regions plotted around the
summary point enable joint inferences to be made about sensitivity and
speciﬁcity. These regions account for correlation between sensitivity
and speciﬁcity, and are useful for illustrating uncertainty around the
summary point and the extent of heterogeneity. Since summary points
should only be calculated when studies share a common threshold, the
available data are reduced. The choice of a common threshold is often
based on the available data and may not be the threshold used in clin-
ical practice. Furthermore, a common threshold is difﬁcult to deﬁne for
non-numeric tests.
The summary point for the MDQ can be estimated by meta-analysis of
only studies that used the recommended threshold of 7. This restriction
reduces the data for meta-analysis from 30 to 19 studies. The summary
sensitivity and speciﬁcity were 0.65 (0.57 to 0.72) and 0.79 (0.72 to
0.84), respectively. Figure 2 shows this summary point with a 95% con-
ﬁdence region and 95% prediction region. The conﬁdence region is
based on the CI around the summery point and indicates that, on the
basis of the available data, we would expect the ‘real value’ to be
within that region 95% of the time. The prediction region around the
summary point indicates the region where we would expect results
from a new study in the future to lie, and is therefore wider than the
conﬁdence region as it goes beyond the uncertainty in the available
data. Despite the use of a common threshold, considerable heterogen-
eity is evident from the plot.
Estimation of a summary curve
The HSROC model focuses on estimation of an SROC curve. The advan-
tage of this approach is that data from each study can be included irre-
spective of the threshold used, thus maximising use of the available
data. Note that only one 2×2 table per study is included in a
meta-analysis, and therefore a choice needs to be made for studies
that report multiple thresholds.11 Although a summary point on an
SROC curve estimated using mixed thresholds is clinically uninterpret-
able, estimates of sensitivity and their CIs can be computed from the
HSROC model at ﬁxed values (eg, lower quartile, median and upper
quartile) of speciﬁcity, or vice versa, to illustrate changes in sensitivity
and speciﬁcity along the curve.
Figure 3 shows the summary curve for the MDQ. To avoid extrapolation
beyond the data, the curve was drawn within the range of observed
speciﬁcities (0.47 to 1.00) from the 30 included studies. For illustration
of a point on the curve, the estimated sensitivity was 0.70 (0.64 to
0.77) at the median speciﬁcity of 0.77 from the included studies. Given
the relationship between the bivariate and HSROC models mentioned
earlier,19 it is possible to estimate summary sensitivity and speciﬁcity
by estimating an average operating point on the SROC curve. This ana-
lysis can be performed separately for studies that report data at a
common threshold. For instance, the summary sensitivity and speciﬁcity
from the HSROC method restricted to studies with threshold 7 are the
same as those obtained from the bivariate model in the preceding
section.
Measuring and explaining heterogeneity
The traditional I2 statistic23 is not recommended for quantifying hetero-
geneity in sensitivity and speciﬁcity because it is a univariate measure
that does not account for potential threshold effects. To investigate
whether a factor is associated with test accuracy, exploratory analyses
can be performed by visual inspection of forest plots and SROC plots.
Where formal investigations are possible, meta-regression can be
performed by adding the factor as a covariate to a hierarchical model.
If there are mixed thresholds, the analysis based on an HSROC model
ﬁtted to all relevant studies will have more power than an analysis at a
ﬁxed threshold. Owing to the complexity of hierarchical models and
paucity of data, it is usual to assess the effect of covariates one at a
time.
The bivariate model allows covariates to affect sensitivity, speciﬁcity or
both. The HSROC model allows covariates to affect the accuracy,
threshold and/or shape of the SROC curve. If SROC curves are assumed
to have the same shape (ie, parallel curves), differences in test per-
formance can be expressed as the relative diagnostic OR (rDORs) com-
paring the DOR of one group of studies to that of another. The ﬁt of
alternative models (effect of adding or removing covariate terms from
the bivariate or HSROC model) can be assessed using statistical tests
to compare models with and without covariate terms. Covariates to be
Table 3 Basic parameters of bivariate and HSROC models
HSROC model Bivariate model
Mean accuracy Mean logit sensitivity
Mean threshold Mean logit specificity
Variance of random effects for
accuracy
Variance of random effects for logit sensitivity
Variance of random effects for
threshold
Variance of random effects for logit specificity
Shape of SROC curve Correlation between the logits of sensitivity and
logits of specificity
Each of the models has five parameters when no covariates are included.
HSROC, hierarchical summary receiver operating characteristic; SROC, summary
ROC.
Table 4 Characteristics of the index tests in the example systematic
review
Characteristic Index tests
Bipolar spectrum
diagnostic scale
Hypomania
checklist
Mood disorder
questionnaire
Number of studies 8 17 30
Range of total score 0–25 points 0–32 points 0–15 points
Recommended thresholds* 13 14 7
*Thresholds recommended by the developers of each screening instrument.32–34
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investigated should be prespeciﬁed with a clear justiﬁcation for their
selection.
The effect of language (Asian vs non-Asian) on the accuracy of the
MDQ was assessed by comparing SROC curves for the two subgroups
of the covariate in one HSROC model (ﬁgure 4). Ten studies used an
Asian language version while 20 studies used a non-Asian language
version of the MDQ (ﬁgure 1). The model was ﬁtted by including covari-
ate terms for accuracy and threshold, but the curves were assumed to
have the same shape. The estimated DOR (95% CI) of Asian and
non-Asian language versions were 5.01 (2.64 to 9.51) and 9.14 (5.90
to 14.1), respectively. The rDOR (95% CI) of 0.55 (0.25 to 1.19) indi-
cates that the DOR of Asian versions was 0.55 times that of the
non-Asian versions, though there was no statistical evidence of a differ-
ence in accuracy (p=0.13).
METHODS FOR COMPARISONS OF MULTIPLE TESTS
Most DTA reviews only evaluate the accuracy of a single test, yet
reviews comparing the accuracy of two or more tests are likely to be of
greater relevance to clinicians and policymakers where decisions need
to be made about selecting tests for use in practice. Different analytic
strategies and meta-analytic models can be used for test comparisons.
These are explained below.
Test comparison strategy
Ideally, test comparisons should focus on studies that have directly
compared the index tests evaluated in the review.8 24 Direct compari-
sons are likely to ensure an unbiased comparison, but such analyses
are not always feasible due to the limited availability of comparative
studies.24 An indirect comparison uses all eligible studies that have
evaluated at least one of the tests of interest, thus maximising use of
the available data. However, the difference in accuracy is prone to
Figure 1 Forest plot of sensitivity and speciﬁcity of the MDQ for detection of any type of bipolar disorder in mental health centre settings . Two
covariates (threshold and language of the instrument) are shown on the plot. The studies are ordered according to the threshold, language of the
instrument (Asian, yes or no) and sensitivity (FN, false negative; FP, false positive; MDQ, mood disorder questionnaire; TN, true negative; TP, true
positive).
Figure 2 Summary receiver operating characteristic plot of the mood
disorder questionnaire (MDQ) at a common threshold of 7 for detection
of any type of bipolar disorder in mental health centre settings. The size
of each point is scaled according to the precision of sensitivity and
speciﬁcity for the study. The solid circle (summary point) represents the
summary estimate of sensitivity and speciﬁcity for the MDQ at a
threshold of 7. The summary point is surrounded by a dotted line
representing the 95% conﬁdence region and a dashed line representing
the 95% prediction region (the region within which we are 95% certain
that the results of a new study will lie).
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confounding due to differences in patient and study characteristics. A
comparative review may include indirect, direct or both types of
comparisons.
Comparison of summary points or SROC curves
Test comparisons may be based on a comparison of summary points
and/or SROC curves. Although points can be estimated at different
common thresholds for each test, the ranking of tests may not be con-
sistent at different thresholds, and therefore a comparison of curves
may be more appropriate in such situations. This is evident in ﬁgure 5A
which shows that the SROC curves for the three tests cross, indicating
that no test is consistently more accurate than any of the others and
relative accuracy depends on the choice of threshold. Current methods
recommended for meta-analysis of test comparisons use a
meta-regression approach, by including test type as a covariate in a
hierarchical model to assess differences in test accuracy.11 This is the
same as the meta-regression approach described earlier for investiga-
tion of heterogeneity. Covariate terms can be allowed to depend on any
of the model parameters shown in table 3, including the variance para-
meters. For an example of a comparison of summary points, see Abba
et al.25 A comparison of SROC curves is illustrated below.
Comparison of the MDQ, BSDS and HCL-32
The diagnostic accuracy of the three tests was compared using an
HSROC meta-regression model. For a full description of the methods
and interpretation of the ﬁndings, see Carvalho et al.22 All 44 studies of
the three tests were included in an indirect comparison (ﬁgure 5A).
There was statistical evidence that the shape of the SROC curves dif-
fered, implying that the relative accuracy of the tests varies with thresh-
olds. For the direct comparisons, eight studies compared the MDQ and
HCL-32 (ﬁgure 5B panel B), and three studies compared the BSDS and
MDQ. None of the 44 studies directly compared the HCL-32 and BSDS.
Although the studies used different thresholds, the results from the
eight studies were consistent with the HCL-32 showing higher sensitiv-
ity and lower speciﬁcity than the MDQ as shown in ﬁgure 5B. The con-
necting line between a pair of points identiﬁes the results for the pair
of tests from each study. A meta-analysis was performed comparing
the MDQ and HCL-32. There was no evidence of a difference in
accuracy.
SOFTWARE OPTIONS AND EXTENSIONS
The statistical packages available for ﬁtting the HSROC model are cur-
rently limited to SAS, WinBUGS and R. These packages can also be
used to ﬁt the bivariate model, as can Stata and MLWin. Review
Manager, the Cochrane Collaboration’s review authoring tool, was used
to produce the forest plot and SROC plots shown in this paper.
Traditionally, the SROC plot is a plot of sensitivity against 1–speciﬁcity
but because interest is often in sensitivity and speciﬁcity, Review
Manager plots sensitivity against speciﬁcity on a reversed scale.
Review Manager cannot be used to ﬁt either hierarchical model but is
useful for exploratory analyses, and for producing forest plots and SROC
plots using parameters from hierarchical models ﬁtted using one of the
statistical packages. SAS programs for ﬁtting hierarchical models for
analysis of a single test, test comparisons and investigations of hetero-
geneity are available in the Cochrane Handbook for DTA reviews.11 An
SAS macro26 that makes ﬁtting the models more accessible and a
tutorial describing how to use RevMan with Stata for different types of
analyses is available at http://dta.cochrane.org/. Other user written pro-
grams are available for Stata (eg, metandi, midas) and R (eg, bamdit,
DiagMeta, mada, HSROC). Extensions to the hierarchical methods dis-
cussed are emerging, in particular to deal with multiple thresholds from
the same study, which require more complex modelling of correlated
data per study.27–30
CONCLUSIONS
In this paper, we have focused on the data analysis in a DTA systematic
review. For a general overview of the DTA review process, see Leeﬂang
Figure 3 Summary receiver operating characteristic plot of the mood
disorder questionnaire (MDQ) at different thresholds for detection of any
type of bipolar disorder in mental health centre settings. Each study
point was scaled according to the precision of sensitivity and
speciﬁcity for the study. The summary curve was drawn restricted to
the range of speciﬁcities (0.47 to 1.00) from the 30 studies included in
the evaluation of the MDQ.
Figure 4 Summary receiver operating characteristic curves comparing
Asian and non-Asian language versions of the mood disorder
questionnaire. Each study point was scaled according to the precision
of sensitivity and speciﬁcity for the study. The summary curves were
drawn restricted to the range of speciﬁcities for each group of studies
(0.47 to 1.00 for non-Asian and 0.53 to 0.95 for Asian studies).
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et al.8 9 Meta-analyses of diagnostic accuracy studies can provide
answers to important clinical questions but the methods recommended
are demanding. We hope our paper will provide clinicians with sufﬁcient
understanding of the terminology and methods to aid interpretation of
systematic reviews and facilitate better patient care. We advise review
teams to seek the support of a statistician if statistical expertise is
lacking in the team. Hierarchical models can be problematic to ﬁt, espe-
cially when there are sparse data. The models may also need to be
simpliﬁed when there are few studies and meta-analysis is judged to
be appropriate.31 The Cochrane Handbook for DTA Reviews11 provides
guidance and is available at http://dta.cochrane.org/. The website also
contains links to training materials and tutorials that can aid review
authors in producing methodologically rigorous reviews. For more exam-
ples of DTA reviews on topics related to mental health, we refer
readers to the Cochrane Library.
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